Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

24-Jul-16 - 22-Jul-17
Buy Ratio:42%

Down

# Net Buyers:134
# Net Sellers:182

Previous 52 Weeks

26-Jul-15 - 23-Jul-16
Buy Ratio:43%
# Net Buyers:147
# Net Sellers:196
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
China Biologic Products, Inc.($21.43M)$1.55B  
Zoetis Inc.($8.59M)$778.93M  
Colucid Pharmaceuticals, Inc.$713.09M$714.49M  
Anacor Pharmaceuticals, Inc.--$238.81M  
Juno Therapeutics, Inc.($222.99M)$152.59M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$713.09M$714.49M  
Tobira Therapeutics, Inc.$72.30M$80.44M  
Abbott Laboratories$23.71M$57.06M  
Alnylam Pharmaceuticals, Inc.$12.84M$27.76M  
Agios Pharmaceuticals Inc$4.01M$21.59M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.84B)($1.83B)  
Seattle Genetics Inc /wa$113.40M($326.31M)  
Incyte Corp($56.66M)($281.29M)  
Catalent, Inc.($412.05M)($184.86M)  
Valeant Pharmaceuticals International, Inc.($217.38M)($117.73M)  
New Net Sellers
CompanyNet Buy AmountChange
Incyte Corp($56.66M)($281.29M)  
Global Blood Therapeutics, Inc.($96.54M)($96.60M)  
Biogen Inc.($326.39K)($77.31M)  
Portola Pharmaceuticals Inc($37.45M)($70.36M)  
Esperion Therapeutics, Inc.($49.26M)($49.65M)